United Therapeutics (UTHR) Assets Average (2010 - 2026)

United Therapeutics has disclosed Assets Average across 17 years of filings, most recently posting $7.0 billion for Q2 2026.

• In Q2 2026, Assets Average fell 10.97% year-over-year to $7.0 billion; the TTM figure through Jun 2026 stood at $7.0 billion (down 10.97% YoY), while the FY2025 annual figure was $7.6 billion, up 4.91% from the prior year.
• Assets Average came in at $7.0 billion for Q2 2026 at United Therapeutics, down from $7.3 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $7.8 billion in Q2 2025 to a low of $5.3 billion in Q1 2022.
• Average Assets Average over 5 years is $6.7 billion, with a median of $6.9 billion recorded in 2023.
• Year-over-year, Assets Average climbed 21.02% in 2023 and slipped 10.97% in 2026.
• Over 5 years, Assets Average stood at $5.9 billion in 2022, then advanced by 19.99% to $7.1 billion in 2023, then gained by 2.09% to $7.2 billion in 2024, then gained by 5.14% to $7.6 billion in 2025, then slipped by 8.51% to $7.0 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $7.0 billion in Q2 2026, $7.3 billion in Q1 2026, and $7.6 billion in Q4 2025.